The project is borne by a non-profit association. Composed of 12 founding members, it brings together:

  • Public players: the National Cancer Institute and the Health Data Hub,
  • Private players: ARIIS, France Biotech and 8 healthcare industry companies (Amgen, AstraZeneca, Janssen, MSD, Novartis, Pfizer, Pierre Fabre, Roche Diagnostics France).

A public / private partnership

The Association embodies the desire to interconnect the strengths of each of its members:

  • ARIIS brings to the whole its uniting vision and capacity to create a space for agile dialogue,
  • The public representatives contribute their national perspective and ensure that the public interest and the proper use of data are respected,
  • The biotech companies and large industry companies provide their capacity for innovation, scale-up and international perspective.

The Association is supported by the French Public Investment Bank (BpiFrance), which contributes €8.2M, and by each of the 8 founding industry companies, each providing €1M over a five-year period. A portion of the subsidies is paid to INCa in order to speed up the development of a Cancer Data Platform open to all. The other portion, in the form of reimbursable advances, will go to the Association so that it can implement the project.

How the “Artificial Intelligence and Cancers” Association is financed